アステラス製薬株式会社
Summary
アステラス製薬株式会社 is registered in Japan and entered in the “Companies Registration” under number 0100-01-034966. Its legal form is 株式会社 (株) – joint-stock company (Japan). アステラス製薬株式会社 is the ultimate parent of a group of 1 subsidiary in 2 countries, as reported to GLEIF. GLEIF gives this reason: no known person controls the entity, for example because its shareholders are diverse. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 23 Oct 2018 and the record was last updated on 23 Oct 2025; the next renewal is due by 23 Oct 2026. GLEIF's ISIN mapping lists 4 ISINs for this LEI.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | 株式会社 (株) joint-stock company (Japan) |
|---|---|
| Register | Companies Registration · Register website |
| Registration number | 0100-01-034966 |
| Registration authority | Legal Affairs Bureau |
| Jurisdiction | Japan |
| Registered address | 日本橋本町2-5-1, 103-8411 東京都 中央区, Japan |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 19 Mar 1939 |
| LEI | 529900IB708DY2HBBB35 |
| LEI status | active |
| LEI first issued | 23 Oct 2018 |
| LEI record last updated | 23 Oct 2025 |
| Next LEI renewal | 23 Oct 2026 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Parent not reported to GLEIF
- Direct parent: no known person controls the entity, for example because its shareholders are diverse.
- Ultimate parent: no known person controls the entity, for example because its shareholders are diverse.
Direct subsidiaries (1)
- Astellas B.V. Netherlands · Leiden
ISINs mapped to this LEI (4)
JP3942400007 · JP394240BNC7 · JP394240BP88 · US04623U1025
4 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.
Other names
- Astellas Pharma Inc. · name in another language